Assessment of Diabetes after Periodontal Treatment

Recruiting

• Conditions: Diabetes and Periodontal Disease; Metabolic and Endocrine - Diabetes; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12605000260628
• Lead Sponsor: The University of Queensland, Oral Care Research Programme

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

HbA1c>6%, Able to give informed consent, Minimum of 12 teeth, Chronic periodontitis.

Exclusion Criteria

Pregnancy, Gross dental caries, Requirement of antibiotic cover for dental treatment, Anticoagulant therapy, other serious illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c[Measured at 6 and 12 months after treatment];C-peptide[Measured at 6 and 12 months after treatment]

Secondary Outcome Measures

Name	Time	Method
Response to periodontal treatment + any added benefit from triclosan toothpaste[Assessed at 2 wks, 6 & 12 months. ];Inflammatory markers, plaque bacteria & antibodies also assessed.[]